Infinimmune operates as a biotechnology company.
Infinimmune operates as a biotechnology company. Infinimmune reinvents antibody discovery with an end-to-end platform to deliver antibody drugs derived directly from the human immune system.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 6, 2022 | Seed | $12M | 9 | Playground Global | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Playground Global | Yes | Seed |
Axial VC | — | Seed |
Benjamin Kim | — | Seed |
Civilization Ventures | — | Seed |
Jacob Becraft | — | Seed |
Joshua Meier | — | Seed |
Paul Conley | — | Seed |
Pear VC | — | Seed |
Ron Alfa | — | Seed |